Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Yigal Volman
43 years of experience
Clinic is certified :
Cystoscopy in Israel typically costs from $900 to $1,500. The final price depends on the clinic tier and the specific city. In the US, similar diagnostics cost around $1,400 on average. Israel offers savings of around 36%. This cost usually covers the procedure and the doctor's fees for the session.
Bookimed Expert Insight: Choosing a university-affiliated hospital provides access to specialists with immense clinical experience. For example, Sourasky Medical Center treats about 1,800,000 patients every year across 240 departments. Specialists there, like those who trained at Harvard Medical School, lead complex genitourinary oncology programs. This clinical volume often ensures high precision in diagnosing bladder and urethral conditions. High-tier centers also use modern simulation units to refine surgical and diagnostic techniques. Patients often find better value in these large multidisciplinary hubs due to the onsite lab facilities.
| Israel | Turkey | Austria | |
| Cystoscopy | from $850 | from $200 | from $500 |
No hidden fees – just official clinic prices. Pay at the clinic for Cystoscopy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Cystoscopy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Cystoscopy journey.
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
The doctor is a highly experienced obstetrician and gynecologist with 25 years of experience. Currently practicing at Tel Aviv Sourasky Hospital, the doctor also serves as a professor of gynecology at the faculty of medicine of Tel Aviv University. The doctor has contributed significantly to medical literature, with 80 scientific articles published in medical journals and 11 textbook chapters authored. Affiliated with numerous medical societies, the doctor is recognized for expertise in the field.
Dr. Garuz Osnat is a clinical professor at Tel Aviv University. She is a specialist in general gynecology and urological gynecology. Dr. Osnat graduated with honors from the Sackler Medical School. She holds both MD and PhD degrees in medical sciences. Her expertise includes treating complex conditions like endometriosis, uterine prolapse, and cervical dysplasia. She practices at Sourasky Medical Center, a Newsweek-ranked top 10 hospital for medical tourists.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.